Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.
Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.
Despite some bandwagon jumping, Artificial Intelligence is leading to some exciting new developments in drug discovery
The UK Government has announced a £55m five-year investment in Medicines Discovery Catapult.
Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry.
Accelerating progress and increasing success rates
OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery.
See how we can help support you with your next drug discovery project.
Speak to us